Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kazuyasu Nakamura
Defucosylated Chimeric Anti-Cc Chemokine Receptor 4 IgG1 With Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma
Cancer Research
Cancer Research
Oncology
Related publications
CXC Chemokine Receptor 3 and CC Chemokine Receptor 4 Expression in T-Cell and NK-Cell Lymphomas With Special Reference to Clinicopathological Significance for Peripheral T-Cell Lymphoma, Unspecified
Clinical Cancer Research
Cancer Research
Oncology
Producing Defucosylated Antibodies With Enhanced in Vitro Antibody-Dependent Cellular Cytotoxicity via FUT8 Knockout CHO-S Cells
Engineering in Life Sciences
Bioengineering
Environmental Engineering
Biotechnology
Artesunate Shows Potent Anti-Tumor Activity in B-Cell Lymphoma
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
CC Chemokine Receptor 7 Contributes to Gi-Dependent T Cell Motility in the Lymph Node
Journal of Immunology
Allergy
Immunology
A Novel Anti‑EGFR Monoclonal Antibody (EMab‑17) Exerts Antitumor Activity Against Oral Squamous Cell Carcinomas via Antibody‑dependent Cellular Cytotoxicity and Complement‑dependent Cytotoxicity
Oncology Letters
Cancer Research
Oncology
NK Cell-Mediated Anti-Leukemia Cytotoxicity Is Enhanced Using a NKG2D Ligand MICA and Anti-Cd20 SCFV Chimeric Protein
European Journal of Immunology
Allergy
Immunology
T Cell Immunity to Lymphoma Following Treatment With Anti-Cd40 Monoclonal Antibody
Journal of Immunology
Allergy
Immunology
Chimeric Antigen Receptor Engineered Human Gamma Delta T Cells; Enhanced Cytotoxicity With Retention of Cross Presentation
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery